.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Polls

Biosimilars Poll: What are the characteristics of a healthy biologics marketplace?

October 28th 2020

Article

Opposing interests make it hard to define what elements are essential for a competitive marketplace.

Biosimilars Poll: What is Your Opinion on Clinical Efficacy Trials?

October 12th 2020

Article

There are diverging opinions on whether comparative efficacy trials add much of value to the evidence for biosimilar approval in the United States.

Biosimilars Poll: What Should Qualify for Interchangeable Status?

September 25th 2020

Article

How quickly and easily biosimilars should be declared interchangeable with reference products has been an ongoing issue.